Group One Trading, L.P. Assembly Biosciences, Inc. Transaction History

Group One Trading, L.P.

$2.68 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.14 - $3.9 $23,854 - $29,628	-7,597 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$3.8 - $4.56 $7,318 - $8,782	-1,926 Reduced 20.22%	7,597 $29,000
Q1 2021 May 12, 2021	SELL	$4.33 - $6.63 $90,202 - $138,116	-20,832 Reduced 68.63%	9,523 $44,000
Q4 2020 Feb 10, 2021	BUY	$4.87 - $17.29 $140,952 - $500,424	28,943 Added 2049.79%	30,355 $184,000
Q3 2020 Nov 12, 2020	BUY	$15.08 - $27.04 $21,292 - $38,180	1,412 New	1,412 $23,000

Q2 2020 Aug 13, 2020	SELL	$14.57 - $23.96 $190,109 - $312,630	-13,048 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$10.27 - $21.23 $134,002 - $277,009	13,048 New	13,048 $194,000
Q4 2019 Feb 10, 2020	SELL	$8.36 - $23.81 $60,434 - $172,122	-7,229 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$9.83 - $14.82 $166,569 - $251,124	-16,945 Reduced 70.1%	7,229 $71,000
Q2 2019 Aug 09, 2019	BUY	$12.9 - $20.8 $105,896 - $170,747	8,209 Added 51.42%	24,174 $326,000
Q1 2019 May 13, 2019	BUY	$17.7 - $24.93 $264,579 - $372,653	14,948 Added 1469.81%	15,965 $314,000
Q4 2018 Feb 06, 2019	SELL	$19.05 - $36.45 $321,487 - $615,130	-16,876 Reduced 94.32%	1,017 $23,000
Q3 2018 Nov 08, 2018	BUY	$34.41 - $44.23 $428,920 - $551,326	12,465 Added 229.64%	17,893 $665,000
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $255,296 - $327,438	-6,511 Reduced 54.54%	5,428 $213,000
Q1 2018 May 11, 2018	SELL	$41.7 - $64.16 $363,415 - $559,154	-8,715 Reduced 42.2%	11,939 $587,000
Q4 2017 Feb 09, 2018	BUY	$28.58 - $49.91 $590,291 - $1.03 Million	20,654 New	20,654 $935,000
Q3 2017 Nov 15, 2017	SELL	$23.08 - $34.92 $18,117 - $27,412	-785 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	785	785 $16,000

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$217,805
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $647M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account